ResearcherUniversity Medical Center Hamburg-EppendorfActive in the last 2 years
Tarik Ghadban
Matched on ORCID iD 0000-0002-1894-9893; OpenAlex author ID A5018442253. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2017: 1 paper · 2018: none · 2019: none · 2020: none · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 4
- RARRES1 marks an immune-cold, chemoresistance-associated malignant epithelial subpopulation enriched in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00262-026-04361-8↗
- The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in PDAC. Co-author DOI 10.3390/cancers14163998↗
- Evaluation of the Hamburg-Glasgow Classification in Pancreatic Cancer: Preoperative Staging by Combining Disseminated Tumor Load and Systemic Inflammation. Co-author DOI 10.3390/cancers13235942↗
- HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. Co-author DOI 10.1007/s10495-016-1332-4↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Cenap Güngör · 3 shared papers, 2017–2026 · strength 0.57
- Paper RARRES1 marks an immune-cold, chemoresistance-associated malignant epithelial subpopulation enriched in pancreatic duct… DOI 10.1007/s00262-026-04361-8↗
- Paper The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in … DOI 10.3390/cancers14163998↗
- Paper HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. DOI 10.1007/s10495-016-1332-4↗
- Heming Ge · 2 shared papers, 2022–2026 · strength 0.50
- Paper RARRES1 marks an immune-cold, chemoresistance-associated malignant epithelial subpopulation enriched in pancreatic duct… DOI 10.1007/s00262-026-04361-8↗
- Paper The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in … DOI 10.3390/cancers14163998↗
- Matthias Reeh · 3 shared papers, 2017–2022 · strength 0.39
- Paper The Extracellular Matrix: A Key Accomplice of Cancer Stem Cell Migration, Metastasis Formation, and Drug Resistance in … DOI 10.3390/cancers14163998↗
- Paper Evaluation of the Hamburg-Glasgow Classification in Pancreatic Cancer: Preoperative Staging by Combining Disseminated T… DOI 10.3390/cancers13235942↗
- Paper HSP90 is a promising target in gemcitabine and 5-fluorouracil resistant pancreatic cancer. DOI 10.1007/s10495-016-1332-4↗
- Gerrit Wolters‐Eisfeld · 1 shared paper, 2026 · strength 0.32
- Thilo Hackert · 1 shared paper, 2026 · strength 0.32
- Jakob Robert Izbicki · 2 shared papers, 2017–2021 · strength 0.20
- Dan Wang · 1 shared paper, 2022 · strength 0.19
- Yuqiang Li · 1 shared paper, 2022 · strength 0.19
- Katharina E. Effenberger · 1 shared paper, 2021 · strength 0.13
- Thaer S. A. Abdalla · 1 shared paper, 2021 · strength 0.13
- Faik Güntac Uzunoglu · 1 shared paper, 2021 · strength 0.13
- Ulrich Friedrich Wellner · 1 shared paper, 2017 · strength 0.07
- Yogesh Kumar Vashist · 1 shared paper, 2017 · strength 0.07
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.